{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-127798","form_type":"8-K","ticker":"GANX","cik":"0001819411","company_name":"Gain Therapeutics, Inc.","filed_at":"2022-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.309312+00:00","generated_at":"2026-06-21T03:32:28.821212+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Gain Therapeutics appoints Gianluca Fuggetta as Principal Accounting Officer","bullets":["Gianluca Fuggetta, Finance Director Corporate Reporting since July 2022, appointed Principal Accounting Officer effective Dec 12, 2022.","Prior to Gain Therapeutics, Fuggetta spent nearly 9 years at PricewaterhouseCoopers, most recently as Assurance Manager.","CFO Salvatore Calabrese, who previously served as both Principal Financial and Accounting Officer, will continue as Principal Financial Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-127798","json":"https://secwatch.observer/filing/0001104659-22-127798.json","markdown":"https://secwatch.observer/filing/0001104659-22-127798.md","text":"https://secwatch.observer/filing/0001104659-22-127798.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819411/000110465922127798/0001104659-22-127798-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819411/000110465922127798/tm2232896d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T03:32:28.821212+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6c0ef3f197","claim":"Salvatore Calabrese changed role as Principal Accounting Officer at Gain Therapeutics, Inc..","evidence_excerpt":"The Company’s Chief Financial Officer, Salvatore Calabrese, who was previously serving as both Principal Financial Officer and Principal Accounting Officer, will continue serving as the Company's Principal Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465922127798/0001104659-22-127798-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Role","value":"Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"78d2f5b90b","claim":"Gianluca Fuggetta was appointed as Principal Accounting Officer at Gain Therapeutics, Inc..","evidence_excerpt":"On December 12, 2022, Gain Therapeutics, Inc. (the \" Company \") appointed Gianluca Fuggetta, its Finance Director, Corporate Reporting, as the Company's Principal Accounting Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465922127798/0001104659-22-127798-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}